Truist Financial’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.3M | Sell |
123,531
-15,016
| -11% | -$280K | ﹤0.01% | 1203 |
|
|
2025
Q1 | $2.65M | Buy |
138,547
+18,986
| +16% | +$364K | ﹤0.01% | 1087 |
|
|
2024
Q4 | $4.31M | Buy |
119,561
+2,434
| +2% | +$87.7K | 0.01% | 895 |
|
|
2024
Q3 | $4.97M | Buy |
117,127
+7,900
| +7% | +$335K | 0.01% | 828 |
|
|
2024
Q2 | $4.4M | Sell |
109,227
-4,300
| -4% | -$173K | 0.01% | 906 |
|
|
2024
Q1 | $4.02M | Buy |
113,527
+26,043
| +30% | +$922K | 0.01% | 967 |
|
|
2023
Q4 | $2.59M | Buy |
+87,484
| New | +$2.59M | ﹤0.01% | 1132 |
|
|
2023
Q2 | – | Sell |
-7,190
| Closed | -$292K | – | 2663 |
|
|
2023
Q1 | $292K | Buy |
+7,190
| New | +$292K | ﹤0.01% | 2249 |
|
|
2022
Q4 | – | Sell |
-4,625
| Closed | -$221K | – | 2666 |
|
|
2022
Q3 | $221K | Buy |
+4,625
| New | +$221K | ﹤0.01% | 2243 |
|
|
2022
Q2 | – | Sell |
-2,096
| Closed | -$244K | – | 2761 |
|
|
2022
Q1 | $244K | Hold |
2,096
| – | – | ﹤0.01% | 2418 |
|
|
2021
Q4 | $315K | Buy |
2,096
+171
| +9% | +$25.7K | ﹤0.01% | 2294 |
|
|
2021
Q3 | $230K | Buy |
+1,925
| New | +$230K | ﹤0.01% | 2458 |
|
|
2021
Q1 | – | Sell |
-3,454
| Closed | -$330K | – | 2695 |
|
|
2020
Q4 | $330K | Sell |
3,454
-2,977
| -46% | -$284K | ﹤0.01% | 2080 |
|
|
2020
Q3 | $730K | Buy |
6,431
+1,418
| +28% | +$161K | ﹤0.01% | 1505 |
|
|
2020
Q2 | $495K | Buy |
5,013
+587
| +13% | +$58K | ﹤0.01% | 1618 |
|
|
2020
Q1 | $284K | Buy |
4,426
+388
| +10% | +$24.9K | ﹤0.01% | 1868 |
|
|
2019
Q4 | $240K | Buy |
+4,038
| New | +$240K | ﹤0.01% | 2242 |
|